News Search Results
Jul 16, 2025, 09:00 ET Congruence Therapeutics Announces Oral Presentation on MC4R Corrector Development Candidate CGX-926 for Early-Onset Obesity at the 3rd Annual Obesity & Weight Loss Drug Development Summit
July 16, 2025 /PRNewswire/ -- Congruence Therapeutics, a computationally-driven biotechnology company building a unique pipeline of correctors for diseases of protein misfolding, including MC4R-deficient genetic obesity, GBA-driven Parkinson's
More news about: Congruence Therapeutics
Jul 16, 2025, 09:00 ET TPEx-Listed HanchorBio Advances Global Impact of HCB101 Immunotherapy
Shanghai, and the San Francisco Bay Area, HanchorBio is a global clinical-stage biotechnology company focusing on immuno-oncology. Led by an experienced team of pharmaceutical industry veterans, the company is focused on reactivating the
More news about: HanchorBio Inc.
Jul 16, 2025, 09:00 ET Pivot Bio Expands World-Class Scientific Advisory Board to Advance the Future of Crop Nutrition
Advisory Board includes: Christopher Voigt, Ph.D. Daniel I.C. Wang Professor of Advanced Biotechnology, MIT; Co-founder, Pivot Bio A visionary in synthetic biology who bridges computation and life sciences, Dr. Voigt
More news about: Pivot Bio, Inc
Jul 16, 2025, 08:30 ET Oncolytics Biotech® Presents Aggregated Translational Data Providing Evidence of Pelareorep's Effectiveness Across Multiple Tumor Types
updated clinical timeline before the end of the third quarter. About Oncolytics Biotech Inc. Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized
More news about: Oncolytics Biotech® Inc.
Jul 16, 2025, 08:13 ET Nutrafol Launches at Ulta Beauty, Expanding National Retail Footprint
formulations. To remain on the cutting edge of innovation, Nutrafol's team of doctors and researchers continues to explore breakthroughs in genetics, biotechnology, and anti-aging. Today, Nutrafol has been adopted by 7,500 healthcare providers nationwide for its trusted, reliable results and earned numerous
More news about: NUTRAFOL
Jul 16, 2025, 08:00 ET Bio-Thera Solutions Announces FDA Accepts Biologics License Application for BAT2506, a Proposed Biosimilar to Simponi®
Intas' biosimilars are manufactured at Intas Pharmaceuticals' state of the art European Union- Good Manufacturing Practices (EU-GMP) certified biotechnology plant located near Ahmedabad, Gujarat. For more information, visit us at www.intaspharma.com.
More news about: Bio-Thera Solutions, Ltd
Jul 16, 2025, 07:05 ET RCKT INVESTOR NOTICE: Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
[email protected]. CASE ALLEGATIONS: Rocket Pharmaceuticals operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases. The Rocket Pharmaceuticals class action lawsuit
More news about: Robbins Geller Rudman & Dowd LLP
Jul 16, 2025, 07:00 ET Safi Biotherapeutics and Functional Fluidics Initiate Collaboration to Validate Health and Quality of Manufactured RBCs
DETROIT, July 16, 2025 /PRNewswire/ -- Safi Biotherapeutics (Safi), a biotechnology company producing stem-cell derived, manufactured human red blood cell (mRBC) products for civilian and military transfusion needs, and Functional
More news about: Safi Biotherapeutics
Jul 16, 2025, 06:30 ET Deerfield Group Acquires Triple Threat Communications to Enhance Healthcare Marketing Strategy and Creative Offerings
GroupDeerfield Group is a full-service integrated marketing, advertising, and communications agency providing innovative solutions for pharmaceutical, biotechnology, health tech, and consumer health companies. Deerfield's solutions are designed to meet the unique needs of healthcare
More news about: Deerfield Group
Jul 16, 2025, 03:14 ET TFS HealthScience Strengthens Global Ophthalmology Unit with Strategic Hires and Integrated Delivery Model
TFS HealthScience is a full-service, global Contract Research Organization (CRO) that partners with biotechnology and pharmaceutical companies to advance innovative treatments and improve patient outcomes. With operations across 50 countries, TFS and its strategic
More news about: TFS HealthScience
Jul 16, 2025, 02:56 ET TFS HealthScience Strengthens Global Ophthalmology Unit with Strategic Hires and Integrated Delivery Model
TFS HealthScience is a full-service, global Contract Research Organization (CRO) that partners with biotechnology and pharmaceutical companies to advance innovative treatments and improve patient outcomes. With operations across 50 countries, TFS and its strategic
More news about: TFS HealthScience
Jul 15, 2025, 22:32 ET Senhwa Biosciences announces first patient dosed in NCI-sponsored pilot study of Pidnarulex (CX-5461) pharmacodynamics in patients with advanced solid tumors
first-in-class molecule targeting novel cancer mechanisms, but also reflects international recognition of Taiwan's biotechnology achievements. This strengthens the company's visibility and strategic position on the global stage in oncology drug development. Trial
More news about: Senhwa Biosciences, Inc.
Jul 15, 2025, 21:00 ET ArkBio's Ziresovir Included into Pediatric RSV Drug Priority List by WHO
Scripps Research Institute, the Institute of Microbiology of Chinese Academy of Sciences, domestic and international biotechnology companies, as well as venture capital institutions. For more information, please visit:
More news about: Arkbio
Jul 15, 2025, 21:00 ET ArkBio's Ziresovir Included into Pediatric RSV Drug Priority List by WHO
Scripps Research Institute, the Institute of Microbiology of Chinese Academy of Sciences, domestic and international biotechnology companies, as well as venture capital institutions. For more information, please visit:
More news about: Arkbio
Jul 15, 2025, 18:17 ET BIOVAXYS ANNOUNCES EXTENSION OF OFFERING CLOSING DATE
receive the required regulatory approvals. With regards to BioVaxys' business, there are a number of risks that could affect the development of its biotechnology products, including, without limitation, the need for additional capital to fund clinical trials, its lack of operating history, uncertainty about
More news about: BioVaxys Technology Corp.
Jul 15, 2025, 16:06 ET ATTENTION NASDAQ: RCKT INVESTORS: Contact Berger Montague About a Rocket Pharmaceuticals Class Action Lawsuit
Rocket Pharmaceuticals, headquartered in Cranbury, New Jersey, is a biotechnology company focused on developing gene therapies for rare diseases. The suit alleges that the Company failed to inform investors
More news about: Berger Montague
Jul 15, 2025, 11:30 ET Optical Measuring Machine Market Size Grows to USD 4.63 Billion by 2031 | CAGR of 7.3% | Exclusive Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jul 15, 2025, 11:00 ET Room AC Market Size expected to reach US$78.60 billion by 2031 | CAGR of 6.1% | Exclusive Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jul 15, 2025, 10:30 ET Atomic Force Microscopy Market worth $762.2 million by 2030 - Exclusive Report by MarketsandMarkets™
data analysis software, which enhances precision and enables multi-dimensional surface characterization in semiconductors, materials science, and biotechnology industries. Moreover, the shift toward high-resolution, non-destructive testing methods accelerates AFM adoption, especially in quality control
More news about: MarketsandMarkets
Jul 15, 2025, 09:50 ET Faruqi & Faruqi Reminds Fortrea Holdings Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 1, 2025 - FTRE
from buy to hold. Among other things, the Jefferies Report cited perceived weaknesses in the Company's business model as a CRO amid pressure on biotechnology funding and suggested that the cost savings Fortrea expects to achieve by exiting the TSAs are "not as material as [o]ne [m]ight think," stating
More news about: Faruqi & Faruqi, LLP
Jul 15, 2025, 09:33 ET Made Scientific and Sentinel BioTherapeutics Announce Strategic Manufacturing Partnership to Advance Ph I/II Allogeneic ePP Encapsulated Cell Therapy Program
South Korea, a world leader in pharmaceuticals and biotechnology. About Sentinel BioTherapeuticsSentinel BioTherapeutics, a portfolio company of RBL LLC, is a clinical-stage biotechnology company pioneering localized immune-modulating therapies for tumors that
More news about: Made Scientific, Inc.
Jul 15, 2025, 09:00 ET SPRIM PRO and ObvioHealth Expand Collaboration to Deliver Digitally Enabled Trials with Scientific Rigor and Global Reach
scientifically powered global boutique CRO with custom solutions that are designed to accommodate all types of clinical trials in biopharmaceutical, biotechnology, medical device/digital therapeutic, infant formula and nutrition, and consumer health industries. SPRIM PRO delivers high-quality clinical trial
More news about: ObvioHealth
Jul 15, 2025, 08:59 ET Immorta Bio, a Scientific Longevity Company, Appoints Pharmaceutical Industry Veteran Dr. Armin Rath as Chief Business Officer
Fla., July 15, 2025 /PRNewswire/ -- Immorta Bio, Inc., a cutting-edge biotechnology company pioneering the science of longevity and committed to "Treating Diseases of Aging and Treating Aging as a Disease™," today announced
More news about: Immorta Bio Inc.
Jul 15, 2025, 08:03 ET Food Supply Security Becomes QuantiPath Under Bold Rebrand
weeks to support engagement and education leading up to the commercial release of GenoPATHx. About QuantiPathQuantiPath is a biotechnology company revolutionizing food safety testing through precision genetic diagnostics. Its flagship product, GenoPATHx, is the only rapid test
More news about: QuantiPath
Jul 15, 2025, 08:01 ET Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort
Aethlon Medical, Inc. (Nasdaq: AEMD), a clinical-stage biotechnology company developing the investigational Aethlon Hemopurifier®, an extracorporeal device for Oncology and other indications, today announced
More news about: Aethlon Medical, Inc.